http://orcid.org/0000-0001-6819-4540
Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Saki Yoneda, Tetsuo Torisu & Susumu Uchiyama. (2021) Development of syringes and vials for delivery of biologics: current challenges and innovative solutions. Expert Opinion on Drug Delivery 18:4, pages 459-470.
Read now
Read now
Ryuta Wada, Makoto Matsui & Nana Kawasaki. (2019) Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. mAbs 11:2, pages 350-372.
Read now
Read now
Articles from other publishers (36)
Naoual Dahmana, Pierre-Louis Destruel, Samantha Facchetti, Vanessa Braun, Vanessa Lebouc, Zana Marin, Sulabh Patel & Gregoire Schwach. (2023) Reversible protein complexes as a promising avenue for the development of high concentration formulations of biologics. International Journal of Pharmaceutics 648, pages 123616.
Crossref
Crossref
Samadhi Vitharana, Joshua M. Stillahn, Derrick S. Katayama, Charles S. Henry & Mark Cornell Manning. (2023) Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Mariana N. São Pedro, Michel H. M. Eppink & Marcel Ottens. (2023)
Application of a fluorescent dye‐based microfluidic sensor for real‐time detection of
mAb
aggregates
. Biotechnology Progress.
Crossref
Crossref
David N. Greenblott, Jingtao Zhang, Christopher P. Calderon & Theodore W. Randolph. (2022) Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations. Biotechnology and Bioengineering 119:12, pages 3596-3611.
Crossref
Crossref
Arpit Arun K. Bana, Priti Mehta & Khushboo Ashok Kumar Ramnani. (2022) Physical Instabilities of Therapeutic Monoclonal Antibodies: A Critical
Review. Current Drug Discovery Technologies 19:6.
Crossref
Crossref
Mariana N São Pedro, Marieke E Klijn, Michel HM Eppink & Marcel Ottens. (2021)
Process analytical technique (
PAT
) miniaturization for monoclonal antibody aggregate detection in continuous downstream processing
. Journal of Chemical Technology & Biotechnology 97:9, pages 2347-2364.
Crossref
Crossref
Sujata Mahapatra, Marco Polimeni, Lorenzo Gentiluomo, Dierk Roessner, Wolfgang Frieß, Günther H. J. Peters, Werner W. Streicher, Mikael Lund & Pernille Harris. (2021) Self-Interactions of Two Monoclonal Antibodies: Small-Angle X-ray Scattering, Light Scattering, and Coarse-Grained Modeling. Molecular Pharmaceutics 19:2, pages 508-519.
Crossref
Crossref
Josef Hartl, Sergej Friesen, Diethelm Johannsmann, Richard Buchner, Dariush Hinderberger, Michaela Blech & Patrick Garidel. (2022) Dipolar Interactions and Protein Hydration in Highly Concentrated Antibody Formulations. Molecular Pharmaceutics 19:2, pages 494-507.
Crossref
Crossref
Adriana-Michelle Wolf Pérez, Nikolai Lorenzen, Michele Vendruscolo & Pietro Sormanni. 2022. Therapeutic Antibodies. Therapeutic Antibodies
57
113
.
Eduardo Fuentes-Lemus, Juan Sebastián Reyes, Luke F. Gamon, Camilo López-Alarcón & Michael J. Davies. (2021) Effect of macromolecular crowding on protein oxidation: Consequences on the rate, extent and oxidation pathways. Redox Biology 48, pages 102202.
Crossref
Crossref
Minquan Xia, Yanru Wang, Long Sheng, Zhaoxia Cai & Xin Zhou. (2021) Positive response to surfactants on the interfacial behavior and aggregation stability of Fab fragments from yolk immunoglobulin. International Journal of Biological Macromolecules 193, pages 1078-1085.
Crossref
Crossref
Eduardo Fuentes-Lemus, Shuwen Jiang, Per Hägglund & Michael J. Davies. (2021) High concentrations of casein proteins exacerbate radical chain reactions and increase the extent of oxidative damage. Food Hydrocolloids 121, pages 107060.
Crossref
Crossref
Francisca Pinheiro, Jaime Santos & Salvador Ventura. (2021) AlphaFold and the amyloid landscape. Journal of Molecular Biology 433:20, pages 167059.
Crossref
Crossref
Talia A. Shmool, Laura K. Martin, Liem Bui-Le, Ignacio Moya-Ramirez, Pavlos Kotidis, Richard P. Matthews, Gerhard A. Venter, Cleo Kontoravdi, Karen M. Polizzi & Jason P. Hallett. (2021) An experimental approach probing the conformational transitions and energy landscape of antibodies: a glimmer of hope for reviving lost therapeutic candidates using ionic liquid. Chemical Science 12:27, pages 9528-9545.
Crossref
Crossref
Diana C. Gomes, Vítor Geraldes, Deborah Fegley & Miguel A. Rodrigues. (2021) Mutual diffusion of proteins in cold concentration gradients measured by holographic interferometry. Chemical Engineering Science 236, pages 116478.
Crossref
Crossref
Wenqian Chen, Xiaoyu Li, Mingxia Guo, Frederik J. Link, Siti S. Ramli, Jinbo Ouyang, Ian Rosbottom & Jerry Y.Y. Heng. (2021) Biopurification of monoclonal antibody (mAb) through crystallisation. Separation and Purification Technology 263, pages 118358.
Crossref
Crossref
Robin Rajan, Sana Ahmed, Neha Sharma, Nishant Kumar, Alisha Debas & Kazuaki Matsumura. (2021) Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials. Materials Advances 2:4, pages 1139-1176.
Crossref
Crossref
Veeren M. Chauhan, Hongyu Zhang, Paul A. Dalby & Jonathan W. Aylott. (2020) Advancements in the co-formulation of biologic therapeutics. Journal of Controlled Release 327, pages 397-405.
Crossref
Crossref
Melissa Holstein, Jessica Hung, Hasin Feroz, Swarnim Ranjan, Cheng Du, Sanchayita Ghose & Zheng Jian Li. (2020) Strategies for high‐concentration drug substance manufacturing to facilitate subcutaneous administration: A review. Biotechnology and Bioengineering 117:11, pages 3591-3606.
Crossref
Crossref
Ngoc B. Pham & Wilson S. Meng. (2020) Protein aggregation and immunogenicity of biotherapeutics. International Journal of Pharmaceutics 585, pages 119523.
Crossref
Crossref
Marieke E. Klijn, Anna K. Wöll & Jürgen Hubbuch. (2019) Apparent protein cloud point temperature determination using a low volume high-throughput cryogenic device in combination with automated imaging. Bioprocess and Biosystems Engineering 43:3, pages 439-456.
Crossref
Crossref
Yoann Le Basle, Philip Chennell, Nicolas Tokhadze, Alain Astier & Valérie Sautou. (2020) Physicochemical Stability of Monoclonal Antibodies: A Review. Journal of Pharmaceutical Sciences 109:1, pages 169-190.
Crossref
Crossref
Jaime Santos, Jordi Pujols, Irantzu Pallarès, Valentín Iglesias & Salvador Ventura. (2020) Computational prediction of protein aggregation: Advances in proteomics, conformation-specific algorithms and biotechnological applications. Computational and Structural Biotechnology Journal 18, pages 1403-1413.
Crossref
Crossref
Deniz B. Temel, Francis Kinderman & Ertan Eryilmaz. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
505
526
.
Steven A. Berkowitz. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
459
479
.
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Crossref
Jürgen Hubbuch, Matthias Kind & Hermann Nirschl. (2019) Preparative Protein Crystallization. Chemical Engineering & Technology 42:11, pages 2275-2281.
Crossref
Crossref
Wei Wang & Satoshi Ohtake. (2019) Science and art of protein formulation development. International Journal of Pharmaceutics 568, pages 118505.
Crossref
Crossref
Vicki Sifniotis, Esteban Cruz, Barbaros Eroglu & Veysel Kayser. (2019) Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation. Antibodies 8:2, pages 36.
Crossref
Crossref
Marco A. Blanco, Harold W. Hatch, Joseph E. Curtis & Vincent K. Shen. (2019) Evaluating the Effects of Hinge Flexibility on the Solution Structure of Antibodies at Concentrated Conditions. Journal of Pharmaceutical Sciences 108:5, pages 1663-1674.
Crossref
Crossref
Max Hebditch, Aisling Roche, Robin A. Curtis & Jim Warwicker. (2019) Models for Antibody Behavior in Hydrophobic Interaction Chromatography and in Self-Association. Journal of Pharmaceutical Sciences 108:4, pages 1434-1441.
Crossref
Crossref
Marieke E. Klijn & Jürgen Hubbuch. (2019) Correlating multidimensional short-term empirical protein properties to long-term protein physical stability data via empirical phase diagrams. International Journal of Pharmaceutics 560, pages 166-174.
Crossref
Crossref
Max Hebditch & Jim Warwicker. (2019) Web-based display of protein surface and pH-dependent properties for assessing the developability of biotherapeutics. Scientific Reports 9:1.
Crossref
Crossref
Wei Wang & Christopher J. Roberts. (2018) Protein aggregation – Mechanisms, detection, and control. International Journal of Pharmaceutics 550:1-2, pages 251-268.
Crossref
Crossref
Marieke E. Klijn & Jürgen Hubbuch. (2018) Application of Empirical Phase Diagrams for Multidimensional Data Visualization of High-Throughput Microbatch Crystallization Experiments. Journal of Pharmaceutical Sciences 107:8, pages 2063-2069.
Crossref
Crossref
Michael R. Turner & Sathy V. Balu-Iyer. (2018) Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins. Journal of Pharmaceutical Sciences 107:5, pages 1247-1260.
Crossref
Crossref